Collagen Matrix Implant for Chondral Defect Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for repairing chondral defects, such as autogenous chondrocyte transplantation and mesenchymal stem cell differentiation, face limitations including limited cell source, low proliferation, phenotypic loss, and impracticality of alginate scaffolds which cause foreign body reactions and immunological responses.
Innovation Solution
A collagen matrix embedded with chondrocyte-like cells differentiated from mesenchymal stem cells using TGF-β1, which secretes glycosaminoglycan and integrates seamlessly with host tissue without lacunae formation, providing a practical surgical graft for defect repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Shape
If alginate or agarose scaffolds are used for cartilage tissue engineering, then various shapes can be cast and substantial chondrogenesis is caused, but poor cell adhesion and uncontrollable degradation occur following diffusion of divalent cations into the surrounding medium
Solution Approach 1:
The patent changes the chemical composition parameters of the scaffold from alginate/agarose to collagen type I, and adjusts the collagen concentration parameter to 0.05-0.3% w/v, which fundamentally alters the degradation behavior and cell interaction properties while maintaining shape casting capability
Solution Approach 2:
The patent creates a composite structure by combining mesenchymal stem cells with collagen type I matrix, forming a cell-matrix complex that integrates cellular components with a biocompatible extracellular matrix framework, improving both cell adhesion and structural stability
2Reliability
If alginate matrices are implanted in vivo to treat full-thickness defects in cartilage, then cartilage repair is attempted, but severe foreign body giant cell reactions and immunological responses occur
Solution Approach 1:
The patent employs collagen type I, a biocompatible and biodegradable material that naturally integrates with host tissue, replacing the problematic alginate matrix. The collagen scaffold is designed to be temporarily supportive, degrading as native cartilage regenerates, thereby avoiding chronic foreign body reactions
Solution Approach 2:
The patent converts the potential harm of scaffold degradation into a benefit by using collagen that degrades in a controlled manner, releasing space for native cartilage ingrowth while avoiding the severe immunological responses caused by alginate degradation products
3Quantity of substance
If pellet culture method is used for chondrogenic differentiation of MSCs, then high cell density is obtained, but tightly aggregated cell mass with large amount of cells forming only small volume of chondral tissue is present
Solution Approach 1:
The patent uses a collagen type I matrix that provides a distributed three-dimensional framework, replacing the compact pellet structure. This flexible matrix allows cells to spread and form tissue throughout a larger volume while maintaining high cell density, eliminating the periphery-necrosis problem of large pellets
4Quantity of substance
If autogenous chondrocytes are expanded in vitro, then cell number is increased, but unique phenotypes may be lost during expansion
Solution Approach 1:
The patent performs chondrogenic differentiation of mesenchymal stem cells in vitro before implantation, using TGF-β1 supplementation and collagen matrix embedding to pre-differentiate cells into chondrocyte-like cells. This preliminary differentiation ensures that the implanted cells already possess the desired cartilage phenotype, preventing phenotype loss during subsequent in vivo expansion
Solution Approach 2:
The patent introduces TGF-β1 as a biochemical mediator during in vitro culture, which directs mesenchymal stem cells to differentiate into chondrocyte-like cells. This intermediary factor maintains phenotype stability by providing continuous differentiation signals during the expansion process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The collagen matrix implant effectively repairs chondral defects by promoting hyaline cartilage formation without gaps between the graft and recipient site, demonstrating significant improvement in patient outcomes as shown by clinical scoring and arthroscopic observations.
Implementation Method 1
cultivating mesenchymal stem cells (MSCs) in a collagen (e.g., type-I or type-II collagen) containing medium containing collagen at a concentration of 1% to 10% w/v and supplemented with TGF-β1 for 7 to 21 days and under conditions allowing differentiation of MSCs to the chondrocyte-like cells
Implementation Method 2
The chondrocyte-like cells secret glycosaminoglycan
Data Source
Figure 1
Figure 2
AI summary
An implant containing a collagen matrix embedded with chondrocyte-like cells, its use in repairing a chondral defect, and a method of preparing the implant.